Submitted by drupal on Sat, 10/27/2012 - 4:51pm NCT01148498 Solanezumab United States Sunday, August 1, 2010 – Friday, August 31, 2012 55 Phase 2 Alzheimer's Disease Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by drupal on
Submitted by drupal on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.